GIP Makes a Comeback! How Tirzepatide, a Dual-Receptor Agonist, Helps with Weight Loss and Blood Sugar Control
For years, GIP was overshadowed by the popular GLP-1 hormone. Now, a new generation of dual-receptor medications is putting GIP back in the spotlight. Discover how tirzepatide works, why it is attracting attention, and what it could mean for people struggling with obesity and type 2 diabetes. Tirzepatide peptides ,how to lose weight For many people, losing weight is not simply about eating less or exercising more. Hormones, appetite, metabolism, and blood sugar all play important roles in how our bodies store and use energy. This is why scientists have spent decades searching for better ways to manage obesity and type 2 diabetes. One surprising breakthrough comes from an old hormone called GIP. First discovered in 1971, GIP (glucose-dependent insulinotropic polypeptide) was once considered a promising target for diabetes treatment. However, researchers initially struggled to demonstrate significant benefits from activating GIP alone. Today, thanks to advances in metabolic s...